Fresenius drops possible sale of blood transfusion unit - spokesman
Reuters
Published Sep 15, 2019 18:48
Fresenius drops possible sale of blood transfusion unit - spokesman
FRANKFURT (Reuters) - German health care group Fresenius (DE:FREG) has abandoned plans to sell its blood transfusion business, a spokesman said on Sunday, confirming a German media report.
Sources had told Reuters in May that Fresenius had approached potential suitors about selling the unit and had hired Goldman Sachs (N:GS) for that purpose.
The Frankfurter Allgemeine Zeitung newspaper reported on Sunday that the company had dropped those plans.
"I confirm that the transfusion business will continue to be operated by Fresenius," a spokesman for the firm said in an email when asked about the report.
He added that after exploring options for the blood transfusion business, Fresenius reached the conclusion that it was best to keep the unit and develop it with investments.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.